Let us introduce one of our amazing sponsors for this year’s Bridging the Gap. Brinter® is a trailblazing Finnish-American 3D bioprinting company. The company makes high-end 3D bioprinting mainstream. Brinter® ONE is an out-of-the-box 3D bioprinting device with several printheads and modules perfected for cancer research, clinical trials, personalized medicine, and stem cell laboratories.
Bioprinting has an important role in the future of life science and Brinter® have a clear vision of what their company’s role is in it.
We would like to share this super interesting article about Brinter®, written by Pharmaceutical-Networking.com. The article is called “The Brinter® vision: accessible bioprinting for life sciences”. It contains information such as an introduction of the Bioprinter platform and how it can be used as a versatile tool for basic research in tissue engineering and regenerative medicine.
Read the full article here.
On Bridging the Gap 2022, Brinter® was presented by Antti Arjonen, Ph.D. Chief Science Officer at Brinter® who discussed the objective view of 3D bioprinting, its current state and its effect on the future of life science.
Comments are closed.